Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortalityDalila Costa, Thomas Reiberger, Philipp Schwabl et al.|Journal of Hepatology|2020Cited by 202
Alcohol Abstinence Improves Prognosis Across All Stages of Portal Hypertension in Alcohol-Related CirrhosisBenedikt Hofer, Thomas Reiberger, Benedikt Simbrunner et al.|Clinical Gastroenterology and Hepatology|2022Cited by 122
Amelioration of systemic inflammation in advanced chronic liver disease upon beta-blocker therapy translates into improved clinical outcomesMathias Jachs, Thomas Reiberger, Lukas Hartl et al.|Gut|2020Cited by 98
Hepatic recompensation according to Baveno <scp>VII</scp> criteria is linked to a significant survival benefit in decompensated alcohol‐related cirrhosisBenedikt Hofer, Thomas Reiberger, Benedikt Simbrunner et al.|Liver International|2023Cited by 85
Clinical Course of Porto-Sinusoidal Vascular Disease Is Distinct From Idiopathic Noncirrhotic Portal HypertensionKatharina Wöran, Bernhard Scheiner, Georg Semmler et al.|Clinical Gastroenterology and Hepatology|2020Cited by 68